Natchitoches Regional Medical Center began drive through testing at the Walk-In Clinic location at 740 Keyser Ave., Monday, Dec. 27 according to CEO Kirk Soileau. There will be testing Mondays and Thursdays from 1-5 p.m. for the next three weeks. Testing may be extended based on demand and changes in positivity rates. The use of Monoclonal Antibody Therapy has been restricted to specific patient criteria.
All NRMC administered infusions will be performed in the Ambulatory Treatment Center. If patients present to the Emergency Department for an MAT, they will be directed to the ATC for scheduling the infusion during normal clinic business hours. As of last week, the FDA has approved Paxlovid, the four-day Pfizer oral regime for COVID-19 positive patients and NRMC is monitoring availability at local pharmacies while awaiting the criteria for prescribing.
Supplies of Paxlovid will be limited until production increases for US supply distribution. NRMC is working the La.Dept. of Hospitals to see when healthcare facilities will be receiving shipments of the Pfizer oral 4-Day regime. Soileau said athe hospital will continue to update as more information becomes available.
Louisiana Coronavirus Information as of Dec.27
•New Cases 12,164
•New Deaths 17
•COVID patients in hospitals 449
•Total Cases 802,537
•Total Deaths 14,970
•COVID Patients on ventilators 27
Those not vaccinated account for:
•69 percent of cases from Dec.9-15
•82 percent of deaths from Dec. 915
•80 percent of current hospitalizations Soileau provided COVID-19 information for Region 7 of the La. Dept of Health that includes Bienville, Bossier, Caddo, Caliborne, DeSoto, Natchitoches, Red River, Sabine and Webster parishes.
The information is of Dec. 27.
•78 COVID patients
•2 on vents Admits and Discharges
•11 new patients
Information, or dashboard, is updated Monday through Friday at https://ldh.la.gov/Coronavirus/. The dashboard i=data lags one day behind daily numbers.